- Home
- THAR vs VERO Comparison
THAR vs VERO Comparison
Compare THAR & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- VERO
- Stock Information
- Founded
- THAR 2017
- VERO N/A
- Country
- THAR United States
- VERO Canada
- Employees
- THAR N/A
- VERO N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- VERO Medical/Dental Instruments
- Sector
- THAR Health Care
- VERO Health Care
- Exchange
- THAR Nasdaq
- VERO Nasdaq
- Market Cap
- THAR 5.5M
- VERO 4.6M
- IPO Year
- THAR 2022
- VERO N/A
- Fundamental
- Price
- THAR $1.82
- VERO $2.62
- Analyst Decision
- THAR Strong Buy
- VERO
- Analyst Count
- THAR 1
- VERO 0
- Target Price
- THAR $17.00
- VERO N/A
- AVG Volume (30 Days)
- THAR 45.3K
- VERO 3.9M
- Earning Date
- THAR 08-08-2025
- VERO 08-12-2025
- Dividend Yield
- THAR N/A
- VERO N/A
- EPS Growth
- THAR N/A
- VERO N/A
- EPS
- THAR N/A
- VERO N/A
- Revenue
- THAR N/A
- VERO $60,997,000.00
- Revenue This Year
- THAR N/A
- VERO N/A
- Revenue Next Year
- THAR N/A
- VERO $7.47
- P/E Ratio
- THAR N/A
- VERO N/A
- Revenue Growth
- THAR N/A
- VERO N/A
- 52 Week Low
- THAR $0.95
- VERO $2.10
- 52 Week High
- THAR $6.39
- VERO $14.50
- Technical
- Relative Strength Index (RSI)
- THAR 62.50
- VERO 56.90
- Support Level
- THAR $1.30
- VERO $2.15
- Resistance Level
- THAR $1.46
- VERO $4.25
- Average True Range (ATR)
- THAR 0.15
- VERO 0.20
- MACD
- THAR 0.05
- VERO 0.01
- Stochastic Oscillator
- THAR 79.41
- VERO 77.05
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.